Hey Batterup. I agree. I am a primary care physician and investor. I think SQ MTX will be used for this reason. We had 2 recent patients in our practice on maximum oral methotrexate and GI side effects. This is another reason why it will be used. Good luck to your wife.
CGEN has been my largest position for years--look at their prediction model. OHRP, large position--eye drop for wet AMD.
I added to my position today-check!. Willing to add more if the selling continues. I did this with CGEN a couple years back---bought a large bunch in the low 3's then added and added, its now 10. Check!
I took a stroll to the REGN board to see if anyone had squalamine on the radar screen. It was fun to read Livermore posting. Most everyone downplayed Livermore's posts and voted with red thumbs. I voted with some Greenies! Livermore, thanks for your work today!
Well, if we don't do the partnership, there would be a lot of internal work that needs to be done. We would have to hire a 3rd employee!
Jerry, why would we sell the company for a billion if we can get 10B in sales? We will have an offer or two, but we will decline. We'll see who is LOL over the next year, or two or three.
I am also an ordinary doctor and ex-pharmacist with a background in pharmacology. I have read every Livermore post for many months now and did my own DD. I am ALL IN. Good luck to you and to Adam F. I appreciate the Livermore posts and hope to read more from him.
CEO presented yesterday at the International Cachexia Conference in Japan re: the previously released phase 2 study with our cachexia drug. Although no new information was released, this was a great audience to get the story out. As a physician, seeing 11 of 18 patients with cancer cachexia wanting to stay on the drug for quality of life, is meaningful. This drug will likely provide an unmet need for many patients.
Actually Jerry, often there is so little to offer this group of patients, many do sign up for hospice to die peacefully. It is often difficult to get these patients to drink a can of ensure. Having a future option to maintain weight have half the patients feel well enough to continue the medication will fill an unmet need.
I agree that OHRP is not getting much attention. That is what interests me. Squalamine working is so not priced in...